Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Front Pediatr ; 9: 722477, 2021.
Article in English | MEDLINE | ID: mdl-34604140

ABSTRACT

The effect of positive fluid balance (FB) on extracorporeal membrane oxygenation (ECMO) outcomes in pediatric patients remains unknown. We sought to evaluate if positive FB in pediatric intensive care unit (PICU) patients with respiratory and/or cardiac failure necessitating ECMO was associated with increased morbidity or mortality. This was a multicenter retrospective cohort study of data from the deidentified PEDiatric ECMO Outcomes Registry (PEDECOR). Patients entered into the database from 2014 to 2017, who received ECMO support, were included. A total of 168 subjects met the study criteria. Univariate analysis showed no significant difference in total FB on ECMO days 1-5 between survivors and non-survivors [median 90 ml/kg (IQR 18-208.5) for survivors vs. median 139.7 ml/kg (IQR 11.2-300.6) for non-survivors, p = 0.334]. There was also no difference in total FB on ECMO days 1-5 in patients with no change in functional outcome as reflected by the Pediatric Outcome Performance Category (POPC) score vs. those who had worsening in POPC score ≥2 at hospital discharge [median 98 ml/kg (IQR 18-267) vs. median 130 ml/kg (IQR 13-252), p = 0.91]. Subjects that required 50 ml/kg or more of blood products over the initial 5 days of ECMO support had an increased rate of mortality with an odds ratio of 5.8 (95% confidence interval of 2.7-12.3; p = 0.048). Our study showed no association of the noted FB with survival after ECMO cannulation. This FB trend was also not associated with POPC at hospital discharge, MV duration, or ECMO duration. The amount of blood product administered was found to be a significant predictor of mortality.

2.
Arterioscler Thromb Vasc Biol ; 33(3): 459-65, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23307875

ABSTRACT

OBJECTIVE: Endothelial dysfunction is associated with atherosclerosis in mice, but it is difficult to reduce cholesterol levels enough to study regression of atherosclerosis in genetically modified mice. The goal of this study was to examine vascular structure and function before and after reducing elevated plasma lipid levels with a genetic switch in Reversa mice, and identify novel mechanisms contributing to structural and functional improvements in the vasculature after reduction of blood lipids. METHODS AND RESULTS: After 6 months of hypercholesterolemia, endothelial function (maximum relaxation to acetylcholine) in aorta was impaired and responses to nitric oxide were unaffected. Further impairment in endothelial function was observed after 12 months of hypercholesterolemia and was associated with reductions in sensitivity to nitric oxide. Expression of dihydrofolate reductase was reduced at 6 and 12 months, and addition of the tetrahydrobiopterin precursor sepiapterin significantly improved endothelial function. Reducing cholesterol levels at 6 months normalized dihydrofolate reductase expression and prevented further impairment in endothelial function. Similar functional changes were observed after 12 months of hypercholesterolemia followed by 2 months of lipid lowering. CONCLUSIONS: Our data suggest that endothelial dysfunction after prolonged hypercholesterolemia is the result of both impairment of sensitivity to nitric oxide and reduced nitric oxide synthase cofactor bioavailability. Both of these changes can be prevented by normalizing blood lipids during moderately severe or advanced atherosclerosis.


Subject(s)
Aorta/physiopathology , Atherosclerosis/physiopathology , Endothelium, Vascular/physiopathology , Vasodilation , Animals , Antioxidants/pharmacology , Aorta/drug effects , Aorta/metabolism , Atherosclerosis/blood , Atherosclerosis/etiology , Atherosclerosis/genetics , Biopterins/analogs & derivatives , Biopterins/metabolism , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cholesterol/blood , Disease Models, Animal , Dose-Response Relationship, Drug , Endothelium, Vascular/drug effects , Endothelium, Vascular/metabolism , Female , Gene Expression Regulation , Hypercholesterolemia/blood , Hypercholesterolemia/complications , Hypercholesterolemia/genetics , Immunohistochemistry , Mice , Mice, Knockout , Nitric Oxide/metabolism , Nitric Oxide Donors/pharmacology , Pterins/metabolism , Receptors, LDL/deficiency , Receptors, LDL/genetics , Tetrahydrofolate Dehydrogenase/metabolism , Time Factors , Vasodilation/drug effects , Vasodilator Agents/pharmacology
3.
Am J Mens Health ; 6(5): 420-6, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22398989

ABSTRACT

Vitamin D deficiency is epidemiologically linked to prostate, breast, and colon cancer. When compared with European American (EA) men, African American (AA) men have increased risk of prostate cancer, but few studies evaluate vitamin D status in AA men. The authors evaluate the biological and environmental predictors of vitamin D deficiency in AA and EA men in Chicago, Illinois, a low ultraviolet radiation environment. Blood samples were collected from 492 men, aged between 40 and 79 years, from urology clinics at three hospitals in Chicago, along with demographic and medical information, body mass index, and skin melanin content using a portable narrow-band reflectometer. Vitamin D intake and ultraviolet radiation exposure were assessed using validated questionnaires. The results demonstrated that Black race, cold season of blood draw, elevated body mass index, and lack of vitamin D supplementation increase the risk of vitamin D deficiency. Supplementation is a high-impact, modifiable risk factor. Race and sunlight exposure should be taken into account for recommended daily allowances for vitamin D intake.


Subject(s)
Black or African American/statistics & numerical data , Vitamin D Deficiency/ethnology , Vitamin D/blood , White People/statistics & numerical data , Adult , Aged , Body Mass Index , Chicago/epidemiology , Forecasting , Humans , Male , Middle Aged , Risk , Seasons , Vitamin D/therapeutic use , Vitamin D Deficiency/epidemiology
4.
Arterioscler Thromb Vasc Biol ; 30(12): 2482-6, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20864669

ABSTRACT

OBJECTIVE: To test the hypothesis that valvular calcium deposition, pro-osteogenic signaling, and function can be altered in mice with advanced aortic valve disease. METHODS AND RESULTS: "Reversa" mice were given a Western-type diet for 12 months and screened for the presence of aortic valve stenosis. Mice with advanced valve disease were assigned to 1 of 2 groups: (1) those with continued progression for 2 months and (2) those with regression for 2 months, in which lipid lowering was accomplished by a genetic switch. Control mice were normocholesterolemic for 14 months. Mice with advanced valve disease had massive valvular calcification that was associated with increases in bone morphogenetic protein signaling, Wnt/ß-catenin signaling, and markers of osteoblastlike cell differentiation. Remarkably, reducing plasma lipids with a genetic switch dramatically reduced markers of pro-osteogenic signaling and significantly reduced valvular calcium deposition. Nevertheless, despite a marked reduction in valvular calcium deposition, valve function remained markedly impaired. Phosphorylated Smad2 levels and myofibroblast activation (indexes of profibrotic signaling) remained elevated. CONCLUSIONS: Molecular processes that contribute to valvular calcification and osteogenesis remain remarkably labile during the end stages of aortic valve stenosis. Although reductions in valvular calcium deposition were not sufficient to improve valvular function in the animals studied, these findings demonstrate that aortic valve calcification is a remarkably dynamic process that can be modified therapeutically, even in the presence of advanced aortic valve disease.


Subject(s)
Aortic Valve Stenosis/metabolism , Aortic Valve/metabolism , Calcinosis/metabolism , Hypercholesterolemia/metabolism , Osteogenesis , Signal Transduction , Animals , Aortic Valve/diagnostic imaging , Aortic Valve/physiopathology , Aortic Valve Stenosis/diagnostic imaging , Aortic Valve Stenosis/genetics , Aortic Valve Stenosis/physiopathology , Apolipoprotein B-100/genetics , Apolipoprotein B-100/metabolism , Bone Morphogenetic Proteins/metabolism , Calcinosis/diagnostic imaging , Calcinosis/genetics , Calcinosis/physiopathology , Carrier Proteins/genetics , Carrier Proteins/metabolism , Disease Models, Animal , Disease Progression , Fibrosis , Hypercholesterolemia/diagnostic imaging , Hypercholesterolemia/genetics , Hypercholesterolemia/physiopathology , Lipids/blood , Mice , Myofibroblasts/metabolism , Myofibroblasts/pathology , Phosphorylation , Receptors, LDL/deficiency , Receptors, LDL/genetics , Smad2 Protein/metabolism , Time Factors , Ultrasonography , Wnt Proteins/metabolism , beta Catenin/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...